Progress in pharmacodynamics and pharmacokinetics of ginsenoside Rg1

Journal of China Pharmaceutical University

Volumn 38, Issue 3, 2007, Pages 283-288

  Zhang, Jing Wei ^a   Wang, Guang Ji ^a   Sun, Jian Guo ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ginsenoside Rg1; Pharmacodynamics; Pharmacokinetics

Indexed keywords

GINSENOSIDE RG 1;

ALZHEIMER DISEASE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG ABSORPTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RESEARCH; DRUG STRUCTURE; ENDOCRINE SYSTEM; HUMAN; IMMUNE SYSTEM; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHARMACODYNAMICS; REVIEW;

EID: 34447131740     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Dou D, Chen Y, Ren J, et al. Ocotillone-type ginsenoside from leaves of Panax ginseng [J]. J Chin Pharm Scie, 2002, 11(4):119-121.
2. Rudakewich M, Ba F, Benishin CG. Neurotrophic and neuroprotective actions of ginsenosides Rb(1) and Rg(1) [J]. Planta Med, 2001, 67 (6):533-537.
3. Chen XC, Zhou YC, Chen Y, et al. Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative Areas [J]. Acta Pharmacol Sin, 2005, 26(1):56-62.
4. Couzin J. Parkinson's disease. Dopamine may sustain toxic protein [J]. Science, 2001, 294(5545):1257-1258.
5. Liao B, Newmark H, Zhou R. Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro [J]. Exp Neurol, 2002, 173(2):224-234.
6. Chen XC, Fang F, Zhu YG, et al. Protective effect of ginsenoside Rg1 on MPP + -induced apoptosis in SHSY5Y cells [J]. J Neural Transm, 2003, 110(8):835-845.
7. Chen XC, Chen Y, Zhu YG, et al. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons [J]. Acta Pharmacol Sin, 2002, 23(9):829-834.
8. Chen F, Eckman EA, Eckman CB. Reductions in levels of the Alzheimer' s amyloid beta peptide after oral administration of ginsenosides [J]. Faseb J, 2006, 20(8):1269-1271.
9. Lü JH, Huang F, Liu YL. J Chin Med Mater, 2005, 28(2):117-119.
10. Wang XY, Chen J, Zhang JT. Acta Pharm Sin, 2001, 36(1):1-4.
11. Mook-Jung I, Hong HS, Boo JH, et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice [J]. J Neurosci Res, 2001, 63(6):509-515.
12. Cheng Y, Shen LH, Zhang JT. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action [J]. Acta Pharmacol Sin, 2005, 26(2):143-149.
13. Zhang RS, Zhang FM, Yang ZJ. Acta Univ Med Nanjing (Nat Sci), 2006, 26(4):242-245.
14. Zhao X, Li Z, Cao YP. J China Med Univ, 2001, 30(6):431-40.
15. Leung KW, Cheng YK, Mak NK, et al. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells [J]. FEBS Lett, 2006, 580(13):3211-3216.
16. Du LP, Yang Q, You QD, J China Pharm Univ, 2006, 37(4):291-296.
17. Kim CS, Son SJ, Kim HS, et al. Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes [J]. Acta Pharmacol Sin, 2005, 26 (5):551-558.
18. Zhang HS, Wang SQ. Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation [J]. J Cell Biochem, 2006, 98(6):1471-1481.
19. Ma ZC, Cao Y, Wang YG, et al. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha [J]. Acta Pharmacol Sin, 2006, 27(8):1000-1006.
20. Lee YJ, Chung E, Lee KY, et al. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor [J]. Mol Cell Endocrinol, 1997, 133(2):135-140.
21. Chung E, Lee KY, Lee YJ, et al. Ginsenoside Rg1 down-regulates glucocorticoid receptor and displays synergistic effects with cAMP [J]. Steroids, 1998, 63(7-8):421-424.
22. Chan RY, Chen WF, Doug A, et al. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng [J]. J Clin Endocrinol Metab, 2002, 87(8):3691-3695.
23. Chen WF, Lau WS, Cheung PY, et al. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1 [J]. Br J Pharmacol, 2006, 147(5):542-551.
24. Ren JH, Chen LF, Zhang LH. Tradit Chin Drug Res Clin Pharmacol, 2002, 13(2):92-93.
25. Lee JH, Han Y. Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4 (+) T cell [J]. Int Immunopharmacol, 2006, 6(9):1424-1430.
26. Sun H, Yang Z, Ye Y. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng [J]. Int Immunopharmacol, 2006, 6(1):14-25.
27. Qian T, Cai Z, Wang RN, et al. In viro rat metabolism and pharmacokinetic studies of ginsenoside Rg3 [J]. J Chromatogr B, 2005, 816(1-2):223-232.
28. Sun J, Wang G, Xie H, et al. Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction [J]. J Pharm Biomed Anal, 2005, 38(1):126-132.
29. Gu Y, Wang G, Sun J, et al. Development of a sensitive LG-ESI-MS assay for 20(R)-ginsenoside Rh2 and its pharmacokinetic application in dogs: A case for the influence of micronization on traditional Chinese medicine [J]. Int J Mass Spectrom, 2006, 252(1):11-19.
30. Zhu S, Zou K, Cai S, et al. Simultaneous determination of triterpene saponins in ginseng drugs by high-perface liquid chromatography [J]. Chem Pharm Bull (Tokyo), 2004, 52(8):995-998.
31. Li L, Zhang JL, Sheng YX, et al. Simultaneous quantification of six major active saponins of Panax notoginseng by high-performance liquid chromatography-UV method [J]. J Pharm Biomed Anal, 2005, 38(1):45-51.
32. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat [J]. Chem Pharm Bull (Tokyo), 1983, 31(1):292-298.
33. Li H, Sun JG, Xie HT. Chin J Clin Pharmacol Ther, 2004, 9(5):510-513.
34. Chao Z, Shoyama Y, Tanaka H. Pharmacokinetic study of ginsenosides Rb1 and Rg1 in rat by ELISA using anti-ginsenosides Rb1 and Rg1 monoclonal antibodies [J]. Am J Chin Med, 2006, 34(6):1069-1081.
35. Han M, Fang XL. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models [J]. Acta Pharmacol Sin, 2006, 27(4):499-505.
36. Shangguan D, Han H, Zhao R, et al. New method for high-performance liquid chromatographic separation and fluorescence detection of ginsenosides [J]. J Chromatogr A, 2001, 910(2):367-372.
37. Huo YS, Zhang SC, Zhou D. Acta Pharmacol Sin, 1986, 7(6):519-521.
38. Liang F, Hua JX. Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine [J]. Eur J Drug Metab Pharmacokinet, 2005, 30(4):261-268.
39. Chinese source.
40. Jin J, Shahi S, Kang HK, et al. Metabolites of ginsenosides as novel BCRP inhibitors [J]. Biomed Biophys Res Commun, 2006, 345(4): 1308-1314.
41. Odani T, Tanizawa H, Takino Y. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. IV. Decomposition of ginsenoside-Rg1 and-Rb1 in the digestive tract of rats [J]. Chem Pharm Bull (Tokyo), 1983, 31(10):3691-3697.
42. Wang Y, Liu TH, Wang W. China J Chin Mater Med, 2001, 26 (3):188-190.
43. Tawab MA, Bahr U, Karas M, et al. Degradation of ginsenosides in humans after oral administration [J]. Drug Metab Dispos, 2003, 31 (8):1065-71.
44. Henderson GL, Harkey MR, Gershwin ME, et al. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity [J]. Life Sci, 1999, 65(15):PL209-214.
45. Chang TK, Chen J, Benetton SA. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1 [J]. Drug Metab Dispos, 2002, 30(4):378-384.
46. Liu Y, Li W, Li P, et al. The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity [J]. Biol Pharm Bull, 2004, 27(10):1555-1560.
47. Liu Y, Ma H, Zhang JW, et al. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes [J]. Planta Med, 2006, 72(2): 126-131.
48. Lü T, Sun JG, Lü H. Chin J Clin Pharmacol Ther, 2006, 11(7):780-783.